The U.S. Food and Drug Administration (FDA) announced updated recommendations for good clinical practices (GCPs) to modernize the design and conduct of clinical trials, making them more agile without compromising data integrity or participant protections.
Proposed in June 2023, the draft guidance is adopted from the International Council for Harmonisation's (ICH) recently updated E6(R3) draft guideline developed to enable the incorporation of rapidly evolving technological and methodological innovations into the clinical trial enterprise.
Modernizing Clinical Trials Requires Agility
Is Public Health Information Trustworthy
A new analysis of 21 surveys published by Heath Affairs indicates changing attitudes about several topics, including trusting vaccine information.
Published on June 6, 2023, these opinion polls were conducted shortly before or during the recent pandemic (2015–23) that met quality standards set by the American Association of Public Opinion Research.
COVID-19-Associated Smell, Taste Disturbance Is Declining
Odds ratios for COVID-19-associated smell or taste disturbance significantly reduced, reaching 0.070 during omicron B peak interval
Almost All Blood Donors Had SARS-CoV-2 Antibodies by Third Quarter of 2022
47.7 percent of those ≥16 years had hybrid immunity, with the lowest prevalence seen for adults aged ≥65 years